| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/07/1996 | CA2197427A1 Gene therapy for transplantation and inflammatory or thrombotic conditions |
| 03/06/1996 | EP0699907A2 Diagnostic methods soluble CD8 T cell surface antigen and anti-CD8 antibody |
| 03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
| 03/06/1996 | EP0699765A1 DNA, constructs, cells and plants derived therefrom |
| 03/06/1996 | EP0699764A1 A method of using eukaryotic expression vectors comprising the BK virus enhancer |
| 03/06/1996 | EP0699761A2 Heptaprenyl diphosphate synthesizing enzyme and dna encoding same |
| 03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
| 03/06/1996 | EP0699757A1 Potyvirus coat protein genes and plants transformed therewith |
| 03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
| 03/06/1996 | EP0699754A1 Method for diagnosing a predisposition for breast and ovarian cancer |
| 03/06/1996 | EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses |
| 03/06/1996 | EP0699752A2 Mutated recombinant collagens |
| 03/06/1996 | EP0699751A1 Antisense complementary to HCV genome |
| 03/06/1996 | EP0699750A1 A collection of phagemids, a collection of Escherichia coli cells carrying the phagemids, a collection of phagemid particles produced from said collection and phagemid particles obtained according to the process |
| 03/06/1996 | EP0699687A2 Process for purifying recombinant human serum albumin |
| 03/06/1996 | EP0699686A2 Biologically active fragments of glucagon-like insulinotropic peptide |
| 03/06/1996 | EP0699306A1 Assay for cardiac troponin i |
| 03/06/1996 | EP0699305A1 Methods, agents and kits for detection of organophosphorus compounds |
| 03/06/1996 | EP0699240A1 Gibbon ape leukemia virus-based retroviral vectors |
| 03/06/1996 | EP0699238A1 Dna encoding two fish neuropeptides |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699210A1 Topical fibrinogen complex |
| 03/06/1996 | EP0699209A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS |
| 03/06/1996 | EP0699208A1 Novel peptide nucleic acids |
| 03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
| 03/06/1996 | EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
| 03/06/1996 | EP0699076A1 Otitis media vaccine |
| 03/06/1996 | EP0699051A1 Macromolecular contrast media for mr imaging |
| 03/06/1996 | EP0652769B1 Vaccines against metazoan parasites |
| 03/06/1996 | EP0528949B1 An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
| 03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
| 03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
| 03/06/1996 | EP0449955B1 Synthetic hiv-like peptides, their compositions and uses |
| 03/06/1996 | EP0416033B1 Macrocyclic chelates and methods of use thereof |
| 03/06/1996 | EP0395653B1 Synovial phospholipases |
| 03/06/1996 | EP0387319B1 Secretory leader sequences |
| 03/06/1996 | EP0362259B1 Method of producing cystatin c or modifications hereof and dna-sequence for use when carrying out the method |
| 03/06/1996 | EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same |
| 03/06/1996 | CN1118144A Method for inactivating viruses devoid of lipid envelopes |
| 03/06/1996 | CN1117973A Obtusatus arthrospira phycocyanin and its application |
| 03/06/1996 | CN1117873A Usage of follicle-stimulating hormone |
| 03/06/1996 | CN1031193C Polypeptide and method for preparing same |
| 03/06/1996 | CA2157531A1 Htfiiia gene |
| 03/05/1996 | USRE35171 Consisting of glutamyl/transferase/gamma-/ and a purified protein having specified molecular weight limits; purification by chromatography |
| 03/05/1996 | US5497228 Laser bevel meter |
| 03/05/1996 | US5496938 Nucleic acid ligands to HIV-RT and HIV-1 rev |
| 03/05/1996 | US5496934 Nucleic acids encoding a cellulose binding domain |
| 03/05/1996 | US5496926 Process of preparing a soluble LDL receptor |
| 03/05/1996 | US5496924 Fusion protein comprising an interleukin-2 fragment ballast portion |
| 03/05/1996 | US5496802 Protein; antibody |
| 03/05/1996 | US5496800 Growth inhibitory factor from urogenital sinus |
| 03/05/1996 | US5496731 Anti-oncogenes |
| 03/05/1996 | US5496724 Genes encoding platelet aggregation inhibitors |
| 03/05/1996 | US5496721 Methods of generating desired amino-terminal residues in proteins |
| 03/05/1996 | US5496714 Modification of protein by use of a controllable interveining protein sequence |
| 03/05/1996 | US5496713 Process for producing 20 kD human growth hormone |
| 03/05/1996 | US5496712 High molecular weight collagen-like protein polymers |
| 03/05/1996 | US5496711 Genetic engineering with dna using fungi, yeasts and bacteria |
| 03/05/1996 | US5496706 Methods and materials for the detection of Staphylococcus aureus |
| 03/05/1996 | US5496705 Monoclonal antibody specific for rat synaptophysin |
| 03/05/1996 | US5496698 Method of isolating ribozyme targets |
| 03/05/1996 | US5496554 Purified mite allergen |
| 03/05/1996 | US5496552 Osteogenic devices |
| 03/05/1996 | US5496551 Polypeptide immunogens |
| 03/05/1996 | US5496550 Method of reducing the output of Eimeria oocysts from a newborn chick |
| 03/05/1996 | CA1338122C Tissue factor inhibitor of coagulation |
| 03/04/1996 | EP0711347A4 Ph genes and their uses |
| 02/29/1996 | WO1996006188A1 Peptide librairies as a source of syngenes |
| 02/29/1996 | WO1996006177A2 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
| 02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
| 02/29/1996 | WO1996006171A2 New polypetides having a toxic activity against insects of the dipterae family |
| 02/29/1996 | WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006168A2 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | WO1996006167A1 Glutamate receptor |
| 02/29/1996 | WO1996006166A1 Improvements in or relating to binding proteins for recognition of dna |
| 02/29/1996 | WO1996006165A1 Genetically engineered swine cells |
| 02/29/1996 | WO1996006164A1 Method for isolating mutant cells |
| 02/29/1996 | WO1996006162A1 HYBRIDOMA THAT EXPRESSES mRNA OF INTERLEUKIN-5 AND METHOD OF SCREENING DRUGS THEREWITH |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006115A1 Product and method for detecting internalin |
| 02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | WO1996006113A1 New immunocontraceptive peptides |
| 02/29/1996 | WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | WO1996006111A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | WO1996006110A1 Composite dna-binding proteins and materials and methods relating thereto |
| 02/29/1996 | WO1996006108A2 Cyclic cs-1 peptidomimetics, compositions and methods of using the same |
| 02/29/1996 | WO1996006107A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 02/29/1996 | WO1996005866A2 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | WO1996005861A1 Compositions and methods for the treatment of body weight disorders, including obesity |
| 02/29/1996 | WO1996005859A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996005855A1 Cartilage disease remedy |
| 02/29/1996 | WO1996005722A1 High-affinity potassium uptake transporter from higher plants |
| 02/29/1996 | DE4431401A1 Lebendvakzine gegen Tumorerkrankungen Live vaccines against tumors |
| 02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
| 02/29/1996 | CA2224401A1 High-affinity potassium uptake transporter from higher plants |